1. Home
  2. VYNE vs JCTC Comparison

VYNE vs JCTC Comparison

Compare VYNE & JCTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • JCTC
  • Stock Information
  • Founded
  • VYNE 2003
  • JCTC 1953
  • Country
  • VYNE United States
  • JCTC United States
  • Employees
  • VYNE N/A
  • JCTC N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • JCTC
  • Sector
  • VYNE Health Care
  • JCTC
  • Exchange
  • VYNE Nasdaq
  • JCTC NYSE
  • Market Cap
  • VYNE 16.0M
  • JCTC 13.2M
  • IPO Year
  • VYNE 2018
  • JCTC 1996
  • Fundamental
  • Price
  • VYNE $1.46
  • JCTC $3.40
  • Analyst Decision
  • VYNE Strong Buy
  • JCTC
  • Analyst Count
  • VYNE 2
  • JCTC 0
  • Target Price
  • VYNE $6.25
  • JCTC N/A
  • AVG Volume (30 Days)
  • VYNE 895.6K
  • JCTC 17.0K
  • Earning Date
  • VYNE 08-13-2025
  • JCTC 07-14-2025
  • Dividend Yield
  • VYNE N/A
  • JCTC N/A
  • EPS Growth
  • VYNE N/A
  • JCTC N/A
  • EPS
  • VYNE N/A
  • JCTC N/A
  • Revenue
  • VYNE $605,000.00
  • JCTC $44,141,421.00
  • Revenue This Year
  • VYNE $42.51
  • JCTC N/A
  • Revenue Next Year
  • VYNE N/A
  • JCTC N/A
  • P/E Ratio
  • VYNE N/A
  • JCTC N/A
  • Revenue Growth
  • VYNE 43.03
  • JCTC N/A
  • 52 Week Low
  • VYNE $0.85
  • JCTC $3.26
  • 52 Week High
  • VYNE $4.30
  • JCTC $5.41
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 56.57
  • JCTC N/A
  • Support Level
  • VYNE $1.10
  • JCTC N/A
  • Resistance Level
  • VYNE $1.49
  • JCTC N/A
  • Average True Range (ATR)
  • VYNE 0.15
  • JCTC 0.00
  • MACD
  • VYNE -0.00
  • JCTC 0.00
  • Stochastic Oscillator
  • VYNE 90.45
  • JCTC 0.00

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.

Share on Social Networks: